Adrenal disease

A new LC-MS/MS assay for serum cortisol, cortisone, and dexamethasone: real-world utility for the interpretation of the 1-mg overnight dexamethasone suppression test

Eur J EndocrinolPublished Diagnostic accuracy study

Authors' conclusion

Very low post-DST DEX concentrations are rare, and DST interpretation often remains informative even when DEX is below conventional thresholds, supporting a selective rather than routine use of DEX measurement. LC-MS/MS cortisol provides excellent discrimination with thresholds close to CLIA practice; cortisone appears best suited as an adjunct marker.

Study context

Population
Patients undergoing 1-mg overnight dexamethasone suppression test (DST): 351 controls, 135 non-functioning adrenal incidentaloma, 14 aldosterone-cortisol cosecretion, 116 mild autonomous cortisol secretion, 20 overt Cushing's syndrome; clinically adjudicated diagnoses
Participants
636 patients
Comparison
Cortisol by chemiluminescent immunoassay (CLIA) vs LC-MS/MS after 1-mg DST
Outcome
AUC for predicting overt hypercortisolism
Methodological detailsconsecutive, real-world observational
  • Consecutive
  • Real-world observational

Performance

As reported in the abstract

Test or modelAUC
CLIA cortisol0.976
LC-MS/MS cortisol0.974
LC-MS/MS cortisone0.959

AUC

CLIA cortisol0.976
LC-MS/MS cortisol0.974
LC-MS/MS cortisone0.959

Further findings

OutcomeCLIA cortisolLC-MS/MS cortisolLC-MS/MS cortisoneP value
AUC for diagnosis of all forms of hypercortisolism
AUC0.9610.9510.931
Post-DST DEX by BMIObesity vs BMI <30 kg/m²P = 0.030
  • Post-DST dexamethasone (DEX) by BMI: Obesity 4.87 ± 2.26 ng/mL
  • Post-DST DEX by BMI: BMI <30 kg/m² 4.40 ± 2.44 ng/mL

Low DEX values and DST interpretability

Lower-tail DEX values were uncommon; even below lower-tail thresholds, DST results often remained clinically interpretable
LC-MS/MS cortisol optimal cut-offs were close to CLIA practice

Original publication

A new LC-MS/MS assay for serum cortisol, cortisone, and dexamethasone: real-world utility for the interpretation of the 1-mg overnight dexamethasone suppression test. Eur J Endocrinol. Published 25 July 2026. doi:10.1093/ejendo/lvag132

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.